MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.rmed.2026.109108

Медицинская библиотека · Respiratory medicine · 2026

Post-bronchodilator FEF25-75 and COPD exacerbations: The role of airflow obstruction severity in the KOCOSS cohort.

Joo Hyonsoo, Park Shinhee, Jang Jong Geol, Lee Hyun, Rhee Chin Kook, Choi Cheon Woong, Hwang Yong Il, Yoo Kwang Ha, Kim Youlim, Moon Ji-Yong

СтатьяПеревод в очереди

Аннотация

BACKGROUND

FEF25-75 is a spirometric index of mid-expiratory flow that is strongly related to conventional airflow obstruction. We evaluated its association with 3-year COPD exacerbations and whether this association was independent of airflow obstruction severity.

METHODS

We analyzed 830 KOCOSS participants (≥40 years; post-BD FEV1/FVC <0.7; ≥10 pack-years) with post-bronchodilator FEF25-75 and complete 3-year exacerbation outcomes. Participants were categorized into quartiles of post-bronchodilator FEF25-75% predicted: Q1, ≥37%; Q2, 26-36%; Q3, 18-25%; and Q4, ≤17%. Logistic regression assessed the risk of at least one moderate-to-severe exacerbation, and negative binomial regression assessed cumulative exacerbation counts. Sequential models adjusted for clinical factors, FVC % predicted, and FEV1% predicted.

RESULTS

The proportion of participants experiencing at least one moderate-to-severe exacerbation increased from 54.0% in Q1 to 81.1% in Q4 (P < 0.001), and the mean cumulative exacerbation count increased from 2.0 to 5.8. In the clinical model, Q4 was associated with a higher risk of exacerbation (OR 2.67, 95% CI 1.66-4.30) and a higher cumulative exacerbation rate (IRR 2.32, 95% CI 1.68-3.19) compared with Q1. These associations persisted after adjustment for FVC, but were no longer significant after adjustment for FEV1 (OR 1.00, 95% CI 0.47-2.11; IRR 1.24, 95% CI 0.75-2.04).

CONCLUSIONS

Lower post-bronchodilator FEF25-75 identifies COPD patients with a higher long-term exacerbation burden; however, this association is predominantly attributable to FEV1-defined airflow obstruction severity. FEF25-75 should therefore be interpreted primarily as a marker of overall physiological impairment rather than an independent, small-airway-specific predictor of exacerbations.

Для цитирования: Joo Hyonsoo, Park Shinhee, Jang Jong Geol, Lee Hyun, Rhee Chin Kook, Choi Cheon Woong, Hwang Yong Il, Yoo Kwang Ha, Kim Youlim, Moon Ji-Yong. Post-bronchodilator FEF25-75 and COPD exacerbations: The role of airflow obstruction severity in the KOCOSS cohort.. Respiratory medicine. 2026. DOI: 10.1016/j.rmed.2026.109108.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.